Wolff-Parkinson-White syndrome catheter ablation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 10: | Line 10: | ||
* Asymptomatic preexcited [[AF]] with rapid conduction over the [[accessory pathway]] in electrophysiology study | * Asymptomatic preexcited [[AF]] with rapid conduction over the [[accessory pathway]] in electrophysiology study | ||
* Asymptomatic preexcitation in specific jobs such as airline pilots, athletes involved in moderate or high level competitive sports | * Asymptomatic preexcitation in specific jobs such as airline pilots, athletes involved in moderate or high level competitive sports | ||
* | * Presence of [[AVRT]] and preexcited [[AF]] | ||
* Presence of atriofascicular( mahain) [[accessory pathway]] | * Presence of atriofascicular( mahain) [[accessory pathway]] | ||
{{Family tree/start}} | |||
{{Family tree| | | | | | A01 | | | |A01= [[Orthodromic AVRT]]}} | |||
{{Family tree| | | | | | |!| | | | | }} | |||
{{Family tree| | | | | | B01 | | | |B01= [[Pre-excitation]] on resting [[ECG]]}} | |||
{{Family tree| | | |,|-|-|^|-|-|-|-|-|-|-|.| | |}} | |||
{{Family tree| | | C01 | | | | | | | | | |C02| |C01= Yes| C02= NO}} | |||
{{Family tree| | | |!| | | | | | | | | | |!| | | | | | | | | |}} | |||
{{Family tree| | |D1 | | | | | | | | | | D2| | | | | | | | |D2= [[Ablation]] candidate, [[patient]] prefers [[ablation]] |D1=[[Ablation]] candidate, willing to undergo [[ablation]] |}} | |||
{{Family tree| | |,|^|-|-|-|-|.| | | | |,|^|-|-|-|-|-|-|-|-|-|-|.|}} | |||
{{Family tree| | |E1 | | | |E2 | | | F1| | | | | | | | |F2 | | | |F1= Yes | E2=Yes|E1=N0 |F2=NO|}} | |||
{{Family tree| |,|^|-|-|.| | | | |!| | | |!| | | | | | | | | | |!| | | | | | }} | |||
{{Family tree| |G1 | | G2| | | H1| |I1 | | | |,|-|-|-|-|+|-|-|-|.| | | |I1= [[Catheter ablation]] (class 1) | H1=[[Catheter ablation]] (class 1)|G2=[[Amiodarone]], [[betablocker]], [[diltiazem]], [[dofetilide]], [[sotalol]], [[verapamil]] (class 2b) |G1=[[Flecainide]] or [[propafenone]] in the absent of [[structural heart disease]] (class 2a) |}} | |||
{{Family tree| |!| | | |!| | | | | | | | | | | | |J1 | | |J2 | | J3| | | | | | | | | J1=[[Betablocker]], [[diltiazem]], [[verapamil]] (class1)|J2=[[Flecainide]], [[propafenone]] in the absent of [[structural heart disease]] (class 2a)|J3= [[Amiodarone]], [[digoxin]], [[dofetilide]], [[sotalol]] (class 2b) }} | |||
{{Family tree| |V1 | |V1 | | | | | | | | | | | |!| | | |!| | | |!| | | | | | | | V1=If ineffective, consider [[ablation]]|}} | |||
{{Family tree| | | | | | | | | | | | | | | | | | | V1| |V1 | |V1 | | | | | | | | | V1=If ineffective, consider [[ablation]] | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
==References== | ==References== | ||
Revision as of 09:25, 5 August 2022
|
Wolff-Parkinson-White syndrome Microchapters |
|
Differentiating Wolff-Parkinson-White syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wolff-Parkinson-White syndrome catheter ablation On the Web |
|
Wolff-Parkinson-White syndrome catheter ablation in the news |
|
Risk calculators and risk factors for Wolff-Parkinson-White syndrome catheter ablation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Rim Halaby, M.D. [3]
Overview
Catheter ablation is indicated in the long term management of patients with Wolff-Parkinson-White (WPW) syndrome.
Catheter Ablation
The indications of catheter ablation in WPW syndrome are as follows:[1]
- Asymptomatic preexcited AF with rapid conduction over the accessory pathway in electrophysiology study
- Asymptomatic preexcitation in specific jobs such as airline pilots, athletes involved in moderate or high level competitive sports
- Presence of AVRT and preexcited AF
- Presence of atriofascicular( mahain) accessory pathway
| Orthodromic AVRT | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pre-excitation on resting ECG | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Yes | NO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ablation candidate, willing to undergo ablation | Ablation candidate, patient prefers ablation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N0 | Yes | Yes | NO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Flecainide or propafenone in the absent of structural heart disease (class 2a) | Amiodarone, betablocker, diltiazem, dofetilide, sotalol, verapamil (class 2b) | Catheter ablation (class 1) | Catheter ablation (class 1) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Betablocker, diltiazem, verapamil (class1) | Flecainide, propafenone in the absent of structural heart disease (class 2a) | Amiodarone, digoxin, dofetilide, sotalol (class 2b) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| If ineffective, consider ablation | If ineffective, consider ablation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| If ineffective, consider ablation | If ineffective, consider ablation | If ineffective, consider ablation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Page, Richard L.; Joglar, José A.; Caldwell, Mary A.; Calkins, Hugh; Conti, Jamie B.; Deal, Barbara J.; Estes III, N.A. Mark; Field, Michael E.; Goldberger, Zachary D.; Hammill, Stephen C.; Indik, Julia H.; Lindsay, Bruce D.; Olshansky, Brian; Russo, Andrea M.; Shen, Win-Kuang; Tracy, Cynthia M.; Al-Khatib, Sana M. (2016). "2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia". Heart Rhythm. 13 (4): e136–e221. doi:10.1016/j.hrthm.2015.09.019. ISSN 1547-5271.